Vertex to Announce Fourth Quarter and Full Year 2024 Financial Results on February 10

Rhea-AI Summary

Vertex Pharmaceuticals (Nasdaq: VRTX) has scheduled its fourth quarter and full year 2024 financial results announcement for Monday, February 10, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET.

Investors can access the call via phone at (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International), referencing the "Vertex Pharmaceuticals Fourth Quarter 2024 Earnings Call". A live webcast will be available through the Investors section of Vertex's website. Participants are advised to register 15 minutes before the scheduled webcast. An archived version will be available on the company's website.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2024 financial results on Monday, February 10, 2025 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the “Vertex Pharmaceuticals Fourth Quarter 2024 Earnings Call.”

The conference call will be webcast live and a link to the webcast can be accessed through Vertex's website at www.vrtx.com in the "Investors" section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1.

Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 15 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and X.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20250127395185/en/

Vertex Pharmaceuticals Incorporated Investor Relations:

investorinfo@vrtx.com

Source: Vertex Pharmaceuticals Incorporated

FAQ

When will Vertex Pharmaceuticals (VRTX) release Q4 and full year 2024 earnings?

Vertex Pharmaceuticals will release its Q4 and full year 2024 earnings on Monday, February 10, 2025, after market close.

How can investors join Vertex's (VRTX) Q4 2024 earnings call?

Investors can join by dialing (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International), or via webcast through Vertex's website investor section at www.vrtx.com.

What time is Vertex Pharmaceuticals' (VRTX) Q4 2024 earnings call?

Vertex's Q4 2024 earnings call is scheduled for 4:30 p.m. ET on February 10, 2025.

Will Vertex's (VRTX) Q4 2024 earnings call be available for replay?

Yes, an archived webcast of the earnings call will be available on Vertex's company website.